Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450912 · ClinicalTrials.gov registry record
Novel Imaging Biomarkers for Mechanical Complications in Acute Myocardial Infarction
A clinical trial, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 250
- Enrollment target
NCT06450912 is a clinical trial that has completed, run by Rohan Dharmakumar. The registered enrollment target is 250 participants.
The verdict
NCT06450912 has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
Hemorrhagic Myocardial infarctions are at high risk for mechanical complications including cardiac rupture. Prediction of vulnerable myocardial segments is an important step for the stratification of hemorrhagic MI patients. Wall motion index ratio is an important parameter to determine regions of high vulnerability within the 17-segment LV model of hemorrhagic MI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2024-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06450912
The ClinicalTrials.gov registry entry for NCT06450912 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rohan Dharmakumar, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06450912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06450912 about?
NCT06450912 is a clinical study titled "Novel Imaging Biomarkers for Mechanical Complications in Acute Myocardial Infarction". Hemorrhagic Myocardial infarctions are at high risk for mechanical complications including cardiac rupture. Prediction of vulnerable myocardial segments is an important step for the stratification of hemorrhagic MI patients. Wall motion index ratio is an important parameter to determine regions of h...
What is the current status of trial NCT06450912?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2022-06-01. Estimated completion is 2024-06-01.
Who is sponsoring clinical trial NCT06450912?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.